Clinical Report: Increased Plasma Levels of Pregnancy Zone Protein as a Possible Indicator of Progression in Diabetic Kidney Disease

Overview

This study investigates the association between elevated plasma levels of pregnancy zone protein (PZP) and the progression of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus.

Background

Diabetic kidney disease (DKD) is a significant complication of type 2 diabetes mellitus (T2DM) and a leading cause of chronic kidney disease (CKD). The increasing prevalence of DKD necessitates the identification of biomarkers.

Data Highlights

Key Findings

• PZP levels were significantly elevated in DKD patients compared to controls.
• Positive correlations were found between plasma PZP and SBP, HbA1c, LDL, Cr, BUN, and UACR.
• Negative correlations were observed between plasma PZP and HDL and eGFR.
• Logistic regression analysis indicated a significant association between PZP levels and DKD progression.
• The ROC curve analysis yielded an area of 0.8143.

Clinical Implications

Monitoring plasma PZP levels may serve as a potential biomarker for assessing the progression of diabetic kidney disease. Early detection of elevated PZP could facilitate timely interventions to manage DKD effectively.

Conclusion

Elevated plasma PZP levels are associated with the progression of diabetic kidney disease.

Related Resources & Content

1. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Proteomic Analysis of Plasma in Diabetic Kidney Disease Among Asians With Early-Onset Type 2 Diabetes
2. Frontiers in Endocrinology, 2023 -- Plasma protein GDF15 has a good predictive potential for the kidney complications of type 2 diabetes
3. Retinal Physician, 2022 -- The Impact of Pregnancy on Diabetic Retinopathy and Its Implications
4. The Journal of Clinical Endocrinology & Metabolism, 2023 -- Plasma Protein Levels as Indicators of Kidney Function Progression in Individuals with Type 2 Diabetes
5. KDIGO 2024 CKD Guideline